Kmg Fiduciary Partners, LLC Amgen Inc Transaction History

Kmg Fiduciary Partners, LLC

$1.14 Billion
Q3 2024

A detailed history of Kmg Fiduciary Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Kmg Fiduciary Partners, LLC holds 7,438 shares of AMGN stock, worth $2.19 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

7,438

Previous 7,429 0.12%

Holding current value

$2.19 Million

Previous $2.32 Million 3.23%

% of portfolio

0.21%

Previous 0.23%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$309.38 - $337.38 $2,784 - $3,036	9 Added 0.12%	7,438 $2.4 Million
Q2 2024 Jul 17, 2024	SELL	$262.75 - $319.31 $6,568 - $7,982	-25 Reduced 0.34%	7,429 $2.32 Million
Q1 2024 Apr 10, 2024	SELL	$268.87 - $324.56 $2.17 Million - $2.62 Million	-8,078 Reduced 52.01%	7,454 $2.12 Million
Q4 2023 Jan 10, 2024	BUY	$255.7 - $288.46 $75,942 - $85,672	297 Added 1.95%	15,532 $4.47 Million
Q3 2023 Oct 25, 2023	BUY	$218.65 - $271.46 $121,788 - $151,203	557 Added 3.79%	15,235 $4.09 Million
Q2 2023 Jul 14, 2023	BUY	$214.27 - $253.37 $1.79 Million - $2.12 Million	8,362 Added 132.39%	14,678 $3.26 Million
Q1 2023 Apr 13, 2023	SELL	$225.79 - $275.2 $116,733 - $142,278	-517 Reduced 7.57%	6,316 $1.53 Million
Q4 2022 Jan 12, 2023	SELL	$229.03 - $291.01 $367,364 - $466,780	-1,604 Reduced 19.01%	6,833 $0
Q3 2022 Oct 27, 2022	SELL	$224.46 - $253.15 $1.1 Million - $1.24 Million	-4,882 Reduced 36.65%	8,437 $1.9 Million
Q2 2022 Jul 13, 2022	SELL	$230.71 - $256.74 $678,056 - $754,558	-2,939 Reduced 18.08%	13,319 $3.24 Million
Q1 2022 Apr 19, 2022	SELL	$219.27 - $242.57 $762,840 - $843,901	-3,479 Reduced 17.63%	16,258 $3.93 Million
Q4 2021 Jan 12, 2022	BUY	$198.88 - $227.6 $141,204 - $161,596	710 Added 3.73%	19,737 $4.44 Million
Q3 2021 Oct 12, 2021	BUY	$212.27 - $248.7 $546,595 - $640,402	2,575 Added 15.65%	19,027 $4.05 Million
Q2 2021 Jul 20, 2021	BUY	$233.58 - $259.14 $89,928 - $99,768	385 Added 2.4%	16,452 $4.01 Million
Q1 2021 Apr 08, 2021	BUY	$221.91 - $258.6 $263,407 - $306,958	1,187 Added 7.98%	16,067 $4 Million
Q4 2020 Jan 13, 2021	BUY	$216.38 - $257.67 $247,105 - $294,259	1,142 Added 8.31%	14,880 $3.39 Million
Q3 2020 Oct 13, 2020	BUY	$234.65 - $260.95 $29,800 - $33,140	127 Added 0.93%	13,738 $3.49 Million
Q2 2020 Jul 22, 2020	BUY	$197.81 - $242.74 $653,762 - $802,255	3,305 Added 32.07%	13,611 $3.21 Million
Q1 2020 Apr 29, 2020	BUY	$182.24 - $241.7 $259,327 - $343,939	1,423 Added 16.02%	10,306 $2.09 Million
Q4 2019 Jan 29, 2020	BUY	$189.21 - $243.2 $669,992 - $861,171	3,541 Added 66.29%	8,883 $2.14 Million
Q3 2019 Oct 15, 2019	SELL	$174.11 - $208.62 $111,430 - $133,516	-640 Reduced 10.7%	5,342 $1.03 Million
Q2 2019 Jul 26, 2019	BUY	$166.7 - $195.41 $71,681 - $84,026	430 Added 7.74%	5,982 $1.1 Million
Q1 2019 Apr 16, 2019	BUY	$180.87 - $203.88 $16,278 - $18,349	90 Added 1.65%	5,552 $1.06 Million
Q4 2018 Apr 15, 2019	BUY	$178.4 - $208.25 $974,420 - $1.14 Million	5,462 New	5,462 $1.06 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kmg Fiduciary Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kmg Fiduciary Partners, LLC with notifications on news.

Account

Kmg Fiduciary Partners, LLC Amgen Inc Transaction History